Cargando…
Enhanced antihyperlipidemic potential of gemfibrozil under co-administration with piperine
Gemfibrozil is a well-known potent antihyperlipidemic drug with the capacity to lower triglyceride and cholesterol levels, which are responsible for most cardiovascular and cerebrovascular diseases. In addition, gemfibrozil has a potent activity at elevating the high density lipoprotein levels. Howe...
Autores principales: | Mohanalakshmi, S., Bhatt, Shvetank, Ashok Kumar, C.K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8663971/ https://www.ncbi.nlm.nih.gov/pubmed/34909656 http://dx.doi.org/10.1016/j.crphar.2021.100021 |
Ejemplares similares
-
Drug–drug Interaction between Pravastatin and Gemfibrozil (Antihyperlipidemic) with Gliclazide (Antidiabetic) in Rats
por: Sultanpur, CM, et al.
Publicado: (2010) -
Effects of the PPARα Agonist and Widely Used Antihyperlipidemic Drug Gemfibrozil on Hepatic Toxicity and Lipid Metabolism
por: Cunningham, Michael L., et al.
Publicado: (2010) -
Bullous dermatosis of childhood induced by gemfibrozil
por: Abtahi-Naeini, Bahareh, et al.
Publicado: (2015) -
Gemfibrozil as a potential heme-independent sGC activator
por: Sobolevsky, Michael, et al.
Publicado: (2011) -
Gemfibrozil enhances the listeriacidal effects of fluoroquinolone antibiotics in J774 macrophages
Publicado: (1992)